Literature DB >> 14614517

Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome.

G Alimena, M Breccia, M Mancini, G Ferranti, L De Felice, C Gallucci, F Mandelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14614517     DOI： 10.1038/sj.leu.2403210

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia.

Authors:  Marija Denčić-Fekete; Vesna Đorđević; Clelia Tiziana Storlazzi; Gradimir Janković; Andrija Bogdanović; Jelica Jovanović; Mariano Rocchi; Biljana Todorić-Živanović; Milica Strnad; Mirjana Gotić
Journal:  Int J Hematol       Date:  2009-03-26       Impact factor: 2.490

2.  Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene.

Authors:  Miki Yamazaki; Chiaki Nakaseko; Masahiro Takeuchi; Shinichi Ozawa; Yasuhiro Ishizuka; Yasuhito Hatanaka; Nagisa Oshima-Hasegawa; Tomoya Muto; Shokichi Tsukamoto; Shio Mitsukawa; Chikako Ohwada; Yusuke Takeda; Naoya Mimura; Tohru Iseki; Motoharu Fukazawa; Emiko Sakaida
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

Review 3.  [Myelodysplastic syndrome with Philadelphia negative+8 clonal chromosomal abnormalities after tyrosine kinase inhibitors therapy for chronic myeloid leukemia: a case report and literature].

Authors:  Y Liu; Y Y Zhang; W Han; X H Zhang; X J Huang; L P Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.